Meet the team: Dr Sophie Foggin
Recently we sat down with Senior Pharmacologist Dr Sophie Foggin to discuss her work Cellomatics’ Pharmacology services. Watch the video below to find out more. https://youtu.be/enSLHKhgSs8?si=0zCWjkvVPhfY_OD1 Click here to view our latest blogs and insights from the team.
Cellomatics shortlisted for BioUK Awards 2026
Cellomatics is thrilled to announce that we have been shortlisted for the BioUK Awards 2026 in the Most Impactful CRO of the Year category. The BioUK Awards (formerly the OBN Awards) is a well-established and highly regarded awards programme for the life sciences industry, designed to celebrate innovation and outstanding achievement across the sector. Now […]
An interview with Study and Operations Director Anushuya Tamang
Recently we sat down with Study and Operations Director Anushuya Tamang to discuss her journey at Cellomatics – having been here since the very beginning! Watch the video below to find out more. https://youtu.be/1RX3qqUz7nw Click here to view our latest blogs and insights from the team.
The impact of macrophage polarisation in inflammation studies
In this blog we discuss the impact macrophage polarisation has in inflammation studies and the ways in which Cellomatics uses this to refine experimental models and inform drug discovery strategies. Inflammation is a fundamental process in human biology. It’s our body’s way of responding to injury or infection, mobilising immune cells to contain damage and […]
Two shortlists for the Pharma Industry Awards 2026
Cellomatics is delighted to have been named as a finalist in both the UK Innovation of the Year — Small category and the Pharma Contract Services Company of the Year — Small category at the Pharma Industry Awards 2026. The Pharma Industry Awards celebrate the most innovative individuals and companies driving excellence in the UK’s […]
Celebrating 10 years of Cellomatics
Earlier this month, Cellomatics proudly celebrated its 10th anniversary, marking a decade of scientific excellence, international growth and significant contributions to the UK life sciences sector. Take a look at some of the images and read more about our anniversary celebrations below. The anniversary celebrations were held at Colwick Hall Hotel on 9 July […]
How PBMC stimulation assays contribute to immunology research
In this blog we discuss PBMC stimulation assays and the ways in which we leverage these assays at Cellomatics to better understand immunity, guide therapy development, and contribute to global scientific knowledge. Peripheral blood mononuclear cells, or PBMCs, are a cornerstone of immunology research. These cells, which include lymphocytes such as T-cells, B-cells, and natural […]
The significance of immune cell chemotaxis in immunology
In this blog we discuss the importance of immune cell chemotaxis and how this can inform the development of therapies, the design of vaccines, and our broader understanding of immune function. In immunology, understanding how immune cells navigate the body is fundamental to both basic science and clinical application. This process, known as immune cell […]
Contract Research Organisation selection – important considerations
In this blog, Cellomatics CEO and Founder Shailendra Singh provides his insights into the important considerations which must be made when identifying and building partnerships with Contract Research Organisations (CROs). Framing the CRO’s role in early discovery In early discovery, the primary role of a CRO is to reduce scientific uncertainty, whereas in later stages […]
Case study: High-throughput functional screening in human translational models for early drug discovery
This case study demonstrates Cellomatics’ capability to integrate: High-throughput screening (HTS) Complex primary human cell models Multiparametric functional readouts Cross-validation of hits in disease-relevant systems Scientific objective To systematically evaluate the functional impact of 100 siRNA-mediated gene knockdowns in primary human keratinocytes derived from both healthy and psoriatic donors, across multiple disease-relevant biological pathways and […]